Aspirin fails to protect against sepsis in elderly
The findings come from the first randomised, placebo-controlled trial to test a possible role for aspirin in primary prevention of sepsis in healthy people
Aspirin taken prophylactically does not reduce the risk of sepsis-related deaths among community-dwelling elderly patients, an Australian study has found.
The negative finding from the ANTISEPSIS (Aspirin To Inhibit Sepsis) trial “reduces hope” for the use of daily low-dose aspirin as a cheap sepsis prevention strategy, the researchers say.
